跳至主要内容
临床试验/CTRI/2023/07/054886
CTRI/2023/07/054886尚未招募2 期

Efficacy of Haridradi Leha in the management of Tamaka Shwasa with respect to Bronchial Asthma- An open labelled randomized controlled clinical trial. - NI

Government Akhandanad Ayurveda College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with chronicity of Tamaka Shwasa less than 10 yrs.
  • Patients present with classical signs and symptoms of Tamaka Shwasa such as ShwasaKrichchhata (Dyspnoea),
  • Ghurghurukama (Wheezing sound),Kasa (Cough),Asamyakanidra (Disturbed sleep),Kantodhwamsa (Hoarseness of voice)
  • Pinasa (Rhinitis),Shleshma Vimokshante Muhurtam Sukham (After expectoration patient feels better)
  • ParshvaAvgrihyate (Chest tightness),Aasinolabhatesaukhyama (Comfortable in sitting position)
  • PEF: >=50-100%

排除标准

  • Patients suffering from Diabetes mellitus.
  • Patients of complicated liver diseases, Renal diseases and cardiac diseases.
  • Patients with poorly controlled hypertension.
  • Patients of Cor pulmonale, Cardiac Asthma and severe exacerbation.
  • Patient with acute and chronic infections like Pneumonitis, Tuberculosis, HIV etc.
  • Patients with major systemic illness RA, SLE and severe metabolic disorders like Gout.
  • Any acute systemic disease or Infection, with post covid lung disease/complication.
  • Pregnant and lactating mothers.
  • Any malignancy.
  • Acute & serious conditions require immediate intervention will be excluded

研究者

发起方
Government Akhandanad Ayurveda College

相似试验